Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older
type: Thing
description: clinical trial
additional property: PropertyValue
  property ID: P17
  value: United States
additional property: PropertyValue
  property ID: P31
  value: clinical trial
additional property: PropertyValue
  property ID: P580
  value: May 25, 2020
additional property: PropertyValue
  property ID: P582
  value: March 31, 2021
additional property: PropertyValue
  property ID: P921
  value: SARS-CoV-2
additional property: PropertyValue
  property ID: P921
  value: mRNA-1273 vaccine
additional property: PropertyValue
  property ID: P1132
  value: +600
additional property: PropertyValue
  property ID: P1476
  value: A Phase 2a, Randomized, Observer-Blind, Placebo Controlled, Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 SARS-COV-2 Vaccine in Adults Aged 18 Years and Older
additional property: PropertyValue
  property ID: P2899
  value: +18
additional property: PropertyValue
  property ID: P3098
  value: NCT04405076
additional property: PropertyValue
  property ID: P4844
  value: mRNA-1273 vaccine
additional property: PropertyValue
  property ID: P6099
  value: phase II clinical trial
additional property: PropertyValue
  property ID: P8005
  value: recruiting
additional property: PropertyValue
  property ID: P8363
  value: interventional study
confidence:
  popularity graph score:
    score: 0.0
    score pct: 0
    tier: long_tail
    components:
      sitelinks: 0
      sitelinks norm: 0.0
      unique citations: 1
      unique citations norm: 0.0
      monthly pageviews: 0
      monthly pageviews norm: 0.0
  sitelinks: 0
  unique citations: 1
  monthly pageviews: 0
  yearly pageviews: 0
  tier: long_tail
claims:
  P17:
    value: Q30
    source count: 0
    confidence: 0.0
    value label: United States
  P31:
    value: Q30612
    source count: 0
    confidence: 0.0
    value label: clinical trial
  P580:
    value: +2020-05-25T00:00:00Z
    source count: 0
    confidence: 0.0
  P582:
    value: +2021-03-31T00:00:00Z
    source count: 0
    confidence: 0.0
  P921:
    value: Q82069695
    source count: 0
    confidence: 0.0
    value label: SARS-CoV-2
  P921:
    value: Q87775025
    source count: 1
    confidence: 0.2
    value label: mRNA-1273 vaccine
  P1132:
    value:
      unit: 1
      amount: +600
    source count: 0
    confidence: 0.0
  P1476:
    value: A Phase 2a, Randomized, Observer-Blind, Placebo Controlled, Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 SARS-COV-2 Vaccine in Adults Aged 18 Years and Older
    source count: 0
    confidence: 0.0
  P2899:
    value:
      unit: http://www.wikidata.org/entity/Q577
      amount: +18
    source count: 0
    confidence: 0.0
  P3098:
    value: NCT04405076
    source count: 0
    confidence: 0.0
  P4844:
    value: Q87775025
    source count: 1
    confidence: 0.2
    value label: mRNA-1273 vaccine
  P6099:
    value: Q42824440
    source count: 0
    confidence: 0.0
    value label: phase II clinical trial
  P8005:
    value: Q76649708
    source count: 0
    confidence: 0.0
    value label: recruiting
  P8363:
    value: Q9164018
    source count: 0
    confidence: 0.0
    value label: interventional study
citations:
  retrieved: 2020-07-12
meta:
  wikidata id: Q95719961
  domain: clinical_trial
  level: standard
  html url: https://4ort.xyz/entity/dose-confirmation-study-to-evaluate-the-safety-reactogenicity-and-immunogenicity-of-mrna-1273-covid-19-vaccine-in-adults-aged-18-years-and-older
  markdown url: https://4ort.xyz/entity/dose-confirmation-study-to-evaluate-the-safety-reactogenicity-and-immunogenicity-of-mrna-1273-covid-19-vaccine-in-adults-aged-18-years-and-older.md
  facts url summary: https://4ort.xyz/entity/dose-confirmation-study-to-evaluate-the-safety-reactogenicity-and-immunogenicity-of-mrna-1273-covid-19-vaccine-in-adults-aged-18-years-and-older/facts.json
  facts url standard: https://4ort.xyz/entity/dose-confirmation-study-to-evaluate-the-safety-reactogenicity-and-immunogenicity-of-mrna-1273-covid-19-vaccine-in-adults-aged-18-years-and-older/facts.json
  facts url full: https://4ort.xyz/entity/dose-confirmation-study-to-evaluate-the-safety-reactogenicity-and-immunogenicity-of-mrna-1273-covid-19-vaccine-in-adults-aged-18-years-and-older/facts.json
  data source: Wikidata (CC0 / public domain)
  license: https://creativecommons.org/publicdomain/zero/1.0/
  api version: v1
  served at: 2026-08-13T21:22:48.573380Z
  entity updated at: 2026-05-03T18:28:36.114423+00:00Z
  entity created at: 2026-05-03T15:17:08.726423+00:00Z